BENEGAS, PAULA; ZIEGLER, BETIANA; DIEMINGER, VICTORIA; BENGIÓ, RAQUEL; ZAPATA, PEDRO; LARRIPA, IRENE; FERRI, CRISTIAN

Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia

GENE; Año: 2024 vol. 896

DE LUCA, GERALDINE; GOETTE, NORA P.; LEV, PAOLA R.; BARONI PIETTO, MARIA C.; MARIN OYARZÚN, CECILIA P.; CASTRO RÍOS, MIGUEL A.; MOIRAGHI, BEATRIZ; SACKMANN, FEDERICO; KAMIYA, LAUREANO J.; VERRI, VERONICA; CAULA, VICTORIA; FERNANDEZ, VANINA; VICENTE, ANGELES; POSE CABARCOS, JULIO; CARUSO, VANESA; CAMACHO, MARIA F.; LARRIPA, IRENE B.; KHOURY, MARINA; MARTA, ROSANA F.; GLEMBOTSKY, ANA C.; HELLER, PAULA G.

Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis

Frontiers in Immunology; Lugar: Lausanne; Año: 2024 vol. 15

TOLOZA, MARÍA JAZMÍN; LINCANGO, MARCO; CAMACHO, MARÍA FERNANDA; LEDESMA, MARTIN MANUEL; ENRICO, ALICIA; MOIRAGHI, BEATRIZ; TOSIN, FERNANDA; MARIANO, ROMINA; PÉREZ, MARIEL; ARANGUREN, PEDRO NEGRI; RIVA, MARÍA ELISA; LARRIPA, IRENE B.; BELLI, CAROLINA B.

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia

ANNALS OF HEMATOLOGY; Lugar: Berlin; Año: 2024

DE LUCA, GERALDINE; LEV, PAOLA R.; CAMACHO, MARIA F.; GOETTE, NORA P.; SACKMANN, FEDERICO; CASTRO RÍOS, MIGUEL A.; MOIRAGHI, BEATRIZ; CORTES GUERRIERI, VERONICA; BENDEK, GEORGINA; CARRICONDO, EMILIANO; ENRICO, ALICIA; VALLEJO, VERONICA; VARELA, ANA; KHOURY, MARINA; GUTIERREZ, MARINA; LARRIPA, IRENE B.; MARTA, ROSANA F.; GLEMBOTSKY, ANA C.; HELLER, PAULA G.

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis

Frontiers in Immunology; Lugar: Lausanne; Año: 2023 vol. 14

BORGES, DANIELA DE PAULA; DOS SANTOS, RINNA MARIA ARRUDA RODRIGUES; VELLOSO, ELVIRA RODRIGUES PEREIRA; RIBEIRO JUNIOR, HOWARD LOPES; LARRIPA, IRENE BEATRIZ; CAMACHO, MARIA FERNANDA; GONZÁLEZ, JACQUELINE; PRATX, LEANDRO DANIEL BURGOS; MAGALHÃES, SÍLVIA MARIA MEIRA; BELLI, CAROLINA BÁRBARA; PINHEIRO, RONALD FEITOSA

Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome

Hematology, Transfusion and Cell Therapy; Lugar: Barcelona; Año: 2023 vol. 45 p. 147 - 153

TOLOZA MJ; BESTACH Y; LINCANGO YUPANKI M; BORDONE J; MARIANO R; TARQUI M; PEREZ M; NEGRI P; ENRICO A; LARRIPA I; BELLI C

.- EXPRESSION DYNAMICS OF THE IMMUNE MEDIATORS ARG, TBET,CIITA,IL10 AND TGFB1 IN CHRONIC MYELOID LEUKAEMIA PATIENTS DURINGTHE FIRST YEAR OF IMATINIB THERAPY

GENE; Lugar: Amsterdam; Año: 2022 vol. 813

BORGES, DANIELA DE PAULA; DOS SANTOS, RINNA MARIA ARRUDA RODRIGUES; VELLOSO, ELVIRA RODRIGUES PEREIRA; RIBEIRO JUNIOR, HOWARD LOPES; LARRIPA, IRENE BEATRIZ; CAMACHO, MARIA FERNANDA; GONZÁLEZ, JACQUELINE; PRATX, LEANDRO DANIEL BURGOS; MAGALHÃES, SÍLVIA MARIA MEIRA; BELLI, CAROLINA BÁRBARA; PINHEIRO, RONALD FEITOSA

Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome

Hematology, Transfusion and Cell Therapy; Año: 2021

RUIZ, MARÍA SOL; SÁNCHEZ, MARÍA BELÉN; BONECKER, SIMONE; FURTADO, CAROLINA; KOILE, DANIEL; YANKILEVICH, PATRICIO; CRANCO, SANTIAGO; CUSTIDIANO, MARÍA DEL ROSARIO; FREITAS, JOSEFINA; MOIRAGHI, BEATRIZ; PÉREZ, MARIEL ANA; PAVLOVSKY, CAROLINA; VARELA, ANA INÉS; VENTRIGLIA, VERÓNICA; SÁNCHEZ ÁVALOS, JULIO CÉSAR; LARRIPA, IRENE; ZALCBERG, ILANA; MORDOH, JOSÉ; VALENT, PETER; BIANCHINI, MICHELE

miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

Frontiers in Pharmacology; Lugar: Lausanne; Año: 2021 vol. 11

SARMIENTO, MARCELA; ROCCA, GABRIELA S.; RAHHAL, MARILINA; LINCANGO YUPANKI, MARCO; ZUBIETA, MARTÍN; METREBIAN, FERNANDA; NARBAITZ, MARINA; LARRIPA, IRENE B.; BELLI, CAROLINA B.

Efficacy of lenalidomide in a patient with systemic mastocytosis associated with SF3B1-mutant myelodysplastic syndrome

LEUKEMIA AND LYMPHOMA; Año: 2021 vol. 62 p. 3027 - 3030

GUTIÉRREZ, LEANDRO G.; ABELLEYRO, MIGUEL M.; RUIZ, MARÍA SOL; ANCHORDOQUI, MARÍA SOL; FREITAS, JOSEFINA; BIANCHINI, MICHELE; DE BRASI, CARLOS D.; LARRIPA, IRENE B.

Development of an inverse-PCR approach for characterization of the major BCR-ABL1 breakpoint sequences on genomic DNA: Proof of concept

CLINICAL CHEMISTRY AND LABORATORY MEDICINE; Año: 2021 vol. 59 p. 449 - 453

GONZALEZ J; PERUSINI A; BASQUEIRA A; ALFONSO G; MACEDO LIMA W; NUCIFORA E; LAZZARINO C; NOVOA V; CAVALCANTI DE ANDRADE SILVA M; LARRIPA I; ARBELBIDE J; VELLOSO E; ALÚ MF, BELLI C, ALFONSO G, SAKAMOTO J, LARRIPA I

PROGNOSTIC ASSESSMENT FOR CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE CONTEXT OF THE WORLD HEALTH ORGANIZATION 2016 PROPOSAL: A MULTICENTER STUDY OF 280 PATIENTS.

ANNALS OF HEMATOLOGY; Lugar: Berlin; Año: 2021 vol. 100 p. 1439 - 1449

RUIZ, MARÍA SOL; SÁNCHEZ, MARÍA BELÉN; VERA CONTRERAS, YULY MASIEL; AGRIELO, EVANGELINA; ALONSO, MARTA; ALTUNA, MARÍA EUGENIA; ANCHORDOQUI, MARÍA SOL; ASINARI, MARIANA; BONETTO, MARÍA ELISA; CAMARGO, MAURICIO; GIERE, ISABEL; GONZÁLEZ, JAVIER; GRANDA ALACOTE, ANA CECILIA; GUERRA, JAVIER; GUTIÉRREZ, MARINA; MALDONADO, CECILIA; MAKIYA, RICARDO; MANRIQUE, GONZALO; MONACO, MARÍA EUGENIA; ROZO, JUAN CARLOS; SANTAMARÍA, CARLOS; SERAVALLE, ANALÍA; ZEA, OLGA; ZUBILLAGA, MARÍA NOEL; MORDOH, JOSÉ; LARRIPA, IRENE; BIANCHINI, MICHELE

Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations

CLINICAL CHEMISTRY AND LABORATORY MEDICINE; Lugar: Berlin; Año: 2020 vol. 0

FERRI, C.; WEICH, N.; GUTIÉRREZ, L.; DE BRASI, C.; BENGIÓ, M.R.; ZAPATA, P.; FUNDIA, A.; LARRIPA, I.

Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia

GENE; Año: 2019 vol. 694 p. 71 - 75

BESTACH Y; TOLOZA MJ; FERRI C; LARRIPA I; BELLI C

The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib⋆

LEUKEMIA RESEARCH; Lugar: Amsterdam; Año: 2019 vol. 86

BACCARANI M; CASTAGNETTI F; GUBLIOTA G; ROSTI G; SOVERINI S; BENGIO R; LARRIPA I

The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview.

LEUKEMIA; Lugar: Londres; Año: 2019 vol. 33 p. 1173 - 1183

ABELLEIRO M; MACHIONI V; PALMITELLI M; RADIC P; LARRIPA I; DE BRASI C; ROSSETTI L

INVERSE PCR TO PERFORM LONG-DISTANCE HAPLOTYPING: MAIN APPLICATIONS TO IMPROVE PREIMPLANTATION GENETIC DIAGNOSIS IN HEMOPHILIA

EUROPEAN JOURNAL OF HUMAN GENETICS; Lugar: Londres; Año: 2019 vol. 27 p. 603 - 611

RUIZ MS; SANCHEZ MB; CUSTIDIANO M; FREITAS F; FONCUBERTA C; GONZALEZ M., GARGALLO P., MOIRAGHI B., LARRIPA I; PAVLOVSKY C; PEREZ M; VENTRIGLIA V; SANCHEZ AVALOS J; MORDOH J; LARRIPA I; BIANCHINI M

EVALUATION OF THE PRIMITIVE AND PROGENITOR FRACTION BY FUNCTIONAL IN VITRO ASSAYS AT THE RNA AND DNA LEVEL REPRESENTS A NOVEL TOOL FOR COMPLEMENTING MOLECULAR MONITORING IN CHRONIC MYELOID LEUKEMIA

oncotarget; Lugar: New York; Año: 2018 vol. 9 p. 20255 - 20264

SCHEPS K; MEYER C; BESTACH Y; ENRICO A; BENGIO R; RODRIGUEZ ZUBIETA M; RIVAS M; DE BRASI C; LARRIPA I

Identification of driver and subclonal mutations in ASXL1 and IDH1/IDH2 genes in an Argentine series of patients with myelofibrosis

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY; Lugar: Londres; Año: 2018

LARRIPA I; MARÍA SOL RUIZ; GUTIERREZ MARINA; BIANCHINI M

Recomendaciones metodológicas para el monitoreo molecular de pacientes con Leucemia Mieloide Crónica por PCR cuantitativa en tiempo real del BCR-ABL1

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2017 vol. 77 p. 61 - 72

BERRO M; PALAU V; RIVAS M; LONGO P; FONCUBERTA C; VITRIU A; REMAGGI G; MARTINEZ ROLON J; JAIMOVICH G ; FELDMAN L ; PADROS K; LARRIPA I; BELLI C; KUSMINSKY G

Transforming Growth Factor-B1 Functional Polymorphisms in Myeloablative Sibling hematopoietic Stem Cell Transplantation

BONE MARROW TRANSPLANTATION; Lugar: Londres; Año: 2017

GUTIERREZ L; NORIEGA F; LAUDICINA A; QUATRIN M; BENGIO R; LARRIPA I

An unusual translocation t(1;11)(q21;q23) in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome

Oncology Letters; Lugar: London; Año: 2017 vol. 13 p. 3159 - 3162

WEICH, NATALIA; ROISMAN, ALEJANDRO; CERLIANI, BELÉN; ARÁOZ, HILDA V.; CHERTKOFF, LILIEN; RICHARD, SILVINA M.; SLAVUTSKY, IRMA; LARRIPA, IRENE B.; FUNDIA, ARIELA F.

Gene polymorphism profiles of drug-metabolising enzymes GSTM1, GSTT1 and GSTP1 in an Argentinian population

ANNALS OF HUMAN BIOLOGY; Año: 2017 vol. 44 p. 379 - 383

BESTACH, YESICA; NAGORE, VIRGINIA PALAU; FLORES, MARÍA G.; GONZÁLEZ, JACQUELINE; ARBELBIDE, JORGE; WATMAN, NORA; SIEZA, YAMILA; LARRIPA, IRENE; BELLI, CAROLINA

Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes

ANNALS OF HEMATOLOGY; Año: 2017 vol. 96 p. 1287 - 1295

ENRICO, ALICIA; BESTACH, YESICA; FLORES, MARIA GABRIELA; ARBELBIDE, JORGE; SERALE, CAMILA; NOVOA, VIVIANA; CRISP, RENÉE; RIVAS, MARÍA MARTA; LARRIPA, IRENE; BELLI, CAROLINA

Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database

Clinical Lymphoma, Myeloma and Leukemia; Lugar: Dallas; Año: 2017 vol. 17 p. 743 - 752

NATALIA WEICH.; CRISTIAN FERRI; BEATRIZ MOIRAGHI; RAQUEL BENGIO; ISABEL GIERE; CAROLINA PAVLOVSKY; IRENE LARRIPA; ARIELA FUNDIA

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome

BLOOD CELLS MOLECULES AND DISEASES; Lugar: Orlando; Año: 2016 vol. 59 p. 129 - 133

WEICH NATALIA; FERRI CRISTIAN; MOIRAGHI BEATRIZ; BENGIÓ RAQUEL; GIERE ISABEL; PAVLOVSKY CAROLINA; LARRIPA IRENE; FUNDIA ARIELA

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response

CANCER EPIDEMIOLOGY; Lugar: Amsterdam; Año: 2016 vol. 44 p. 16 - 21

MARÍA SOL RUIZ; MEDINA M; TAPIA I; JOSE MORDOH; CROSS N; LARRIPA I; BIANCHINI M

Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators

LEUKEMIA; Lugar: Londres; Año: 2016 vol. 30 p. 2258 - 2260

WEICH N; CERLIANI B; ARAOZ H; CHERKOFF L; RICHARD S; FUNDIA A., COTTLIAR A,, LA MOTTA G, CRIVELLI A, GÓMEZ JC, SLAVUTSKY I, LARRIPA I; LARRIPA I; FUNDIA A

GENE POLYMORPHISM PROFILES OF DRUG-METABOLIZING ENZYMES GSTM1, GSTT1 AND GSTP1 IN AN ARGENTINEAN POPULATION

ANNALS OF HUMAN BIOLOGY; Lugar: Londres; Año: 2016

BELLI C; FEITOSA PINHEIRO R; BESTACH Y; LARRIPA I; DA SILVA T; ALFONSO G; GONZALEZ J; MOSENHAIN M; WATMAN N; RIVELLO H; MAGALHAES M; VALLADARES M; UNDURRAGA M; VELLOSO E

CLINICAL CHARACTERISTICS AND PROGNOSIS IN SOUTH-AMERICAN PATIENTS WITH MYELODYSPLASTIC SYNDROME: A MULTICENTER STUDY

AMERICAN JOURNAL OF HEMATOLOGY; Lugar: New York; Año: 2015 vol. 90 p. 851 - 858

LOPEZ, JL, BENDIT, I, PAGNANO K, HOKAMA P, ZALBERG I, PEREIRA N, GIERI I, LARRIPA I, GUEVARA G, ORDUZ R; BENDIT I; BOQUIMPONI C; DE SOUZA C; MIRANDA E; ZALCKERG I; LARRIPA I.; NADINELLI L; SILVEIRA R; FOGLIATTO L; FUNKE V; PASQUINI R; HUNGRIA V; CHIATTONE C; CLEMENTINO N; CONCHON M; MOIRAGHI B; VARELA A; LOPEZ J; PAVLOVSKY C; MAGARIÑOS A; FANILLA E; CORTES J; BENGIO R

BCR-ABL MUTATIONS IN CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS - IMPACT ON SURVIVAL ? A STUDY ON BEHALF OF LATIN AMERICAN LEUKEMIA NET

CANCER INVESTIGATION; Lugar: Abingdon, Oxford; Año: 2015 vol. 33 p. 451 - 458

FERRI C; BIANCHINI M; BENGIO R; MOIRAGHI B; GONZALEZ M; NORIEGA F; LARRIPA I

CLINICAL ACTIVITY OF PONATINIB IN ONE PATIENT WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE WITH E19A2 TRANSCRIPT AND T315I MUTATION

EUROPEAN JOURNAL OF HAEMATOLOGY; Lugar: Londres; Año: 2015

WEICH N; NUNEZ M; GALIMBERTI G; ELENA G; ACEVEDO S; LARRIPA I; DE DIOS SOLER M, NARBAITZ M, LARRIPA I, FUNDIA A

POLYMORPHIC VARIANTS OF GSTM1, GSTT1 AND GSTP1 GENES IN CHILDHOOD ACUTE LEUKEMIAS: A PRELIMINARY STUDY IN ARGENTINA

HEMATOLOGY; Lugar: London; Año: 2015 vol. 20 p. 511 - 516

BESTACH Y; SIEZA Y; ATTIE M; RICCHIERI C; VERRI V; BOLESINA M; BENGIO R; LARRIPA I; BELLI C

POLYMORPHISMS IN TNF AND IFNG ARE ASSOCIATED WITH CLINICAL CHARACTERISTICS OF APLASTIC ANEMIA IN ARGENTINEAN POPULATION.

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2015 vol. 56 p. 1793 - 1798

RADIC P; ROSSETTI L; ABELLEYRO M; TETZLAFF T; CANDELA M; SCIUCCATTI G; BONDUEL M; MEDINA ACOSTA E; I. LARRIPA; DE TEZANOS PINTO M; DE BRASI C

PHENOTYPE GENOTYPE CORRELATIONS IN HEMOPHILIA A CARRIERS ARE CONSISTENT WITH THE BINARY ROLE OF THE PHASE BETWEEN F8 AND X-CHROMOSOME INACTIVATION

JOURNAL OF THROMBOSIS AND HAEMOSTASIS; Lugar: Londres; Año: 2015 vol. 13 p. 530 - 539

ABELLEYRO M; RADIC P; TETZLAFF T; MARCHIONE V; FUNDIA A; LARRIPA I; ROSSETTI L; DE BRASI C

RELIABLE AND COST-EFFECTIVE APPROACH FOR DIAGNOSIS Of. HETEROZYGOUS F8/F9 LARGE DELETIONS BY QUANTITATIVE REAL-TIME PCR

HAEMOPHILIA; Lugar: Oxford; Año: 2015 vol. 21 p. 247 - 251

NORIEGA MARÍA FERNANDA; FERRI CRISTIAN; ICARDI GUSTAVO; BULLORSKY EDUARDO; KORIN JORGE; LARRIPA IRENE

NEW MUTATION L324M IN THE ABL1 KINASE DOMAIN DOES IT CONFER HIGH RESISTANCE TO INHIBITORS OF SECOND GENERATION?

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2014 vol. 55 p. 698 - 701

GONZALEZ M.; DE BRASI C; FERRI C.; BENGIO R; BIANCHINI M.; LARRIPA I

CAMKIIg, HSP70 AND HSP90 TRANSCRIPTS ARE DIFFERENTIALLY EXPRESSED IN RESISTANT MUTATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2014 vol. 55 p. 2101 - 2108

FERRI C; BIANCHINI M; BENGIÓ R; LARRIPA I

EXPRESSION OF LYN AND PTEN GENES IN CHRONIC MYELOID LEUKEMIA AND THEIR IMPORTANCE IN THERAPEUTIC STRATEGY

BLOOD CELLS MOLECULES AND DISEASES; Lugar: Amsterdam; Año: 2014 vol. 52 p. 121 - 125

GONZALEZ M; DE BRASI C; BIANCHINI M; GARGALLO P; STANGANELLI C; ZALCKERG I; LARRIPA I

Improved diagnosis of the transition to JAK2 V617F homozygosis: the key feature to predict evolution of myeloproliferative neoplasms

PLOS ONE; Lugar: San Francisco; Año: 2014 vol. 9 p. 1 - 8

BELLI C.; BESTACH Y; GIUNTA M; IASTREBNER M; SANTOS I; PINTOS N; ARBELBIDE J; BASQUEIRA AL; BENGIÓ R; LARRIPA I

- APPLICATION OF THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM FOR MYELODYSPLASTIC SYNDROMES IN ARGENTINEAN PATIENTS

ANNALS OF HEMATOLOGY; Lugar: Berlin; Año: 2014 vol. 93 p. 705 - 707

FUNDIA A; WEICH N; CRIVELLI A; LA MOTTA G; LARRIPA I; SLAVUTSKY I

Glutathione S-transferase gene polymorphisms in celiac disease and their correlation with genomic instability phenotype.

Clinic and Research in Hepatology and Gastroenterology; Año: 2014

LARRIPA I; BIANCHINI M

Cuantificación de los transcriptos BCR-ABL1 y evaluación de la respuesta molecular en leucemia mieloide crónica

Hematologia; Lugar: Buenos Aires; Año: 2014 vol. 18 p. 164 - 168

BELLI C; BESTACH Y; PRATES V; SAKAMOTO F; ALFONSO G; NARBAITZ M; GONZALEZ J; BENGIÓ R; LARRIPA I

Aplicación del Sistema Pronóstico Internacional revisado (IPSS-R) en 511 pacientes con Síndromes Mielodisplásicos de población Argentina

Hematologia; Lugar: Buenos Aires; Año: 2014 vol. 18 p. 17 - 25

RADIC P; ROSSETTI L; ABELLEYRO M; CANDELA M; PEREZ BIANCO M; TEZANOS PINTO M; LARRIPA I; DE BRASI C

ASSESSMENT OF THE F9 GENOTYPE- SPECIFIC FIX INHIBITOR RISKS AND CHARACTERIZATION OF 10 NOVEL SEVERE F9 DEFECTS IN THE FIRST MOLECULAR

THROMBOSIS AND HAEMOSTASIS; Lugar: Stuttgart ; Año: 2013 vol. 109 p. 24 - 33

ROSSETTI; SZURKALO I; RADIC P; ABELLEYRO M; PRIMIANI L; NEME D; CANDELA M; PEREZ BIANCO M; TEZANOS PINTO M; LARRIPA I; DE BRASI C

Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks

HAEMOPHILIA; Lugar: Londres; Año: 2013 vol. 19 p. 511 - 518

FERRI C; BIANCHINI M; ICARDI G; BELLI C; BENGI¨® R; LARRIPA I

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR.ABL1 gene combining high-resolution melting analysis and mutant allele specific quantitative polymerase chain reaction

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2013 vol. 54 p. 598 - 606

BELLI C; BESTACH Y; KORNBLIT L; LARRIPA I

Prognostic Implications of Cytogenetic Features in Myelodisplastic syndrome

Oncology & Hematology Reviews; Lugar: Londres; Año: 2013 vol. 9 p. 60 - 67

BELLI C; BESTACH Y; CORREA W; SAKAMOTO F; FLORES MG; BASQUEIRA AL; RIVAS MM; CAMPESTRI R; BENGIÓ R; LARRIPA I

Prognostic relevance of cytogenetic systems in myelodysplastic syndromes

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2012 vol. 53 p. 1640 - 1642

ABELLEYRO M; ROSSETTI L; RADIC CP; CANDELA M; LARRIPA I; DE BRASI C

Are int22h-mediated deletions a common cause of hemophilia?

ANNALS OF HEMATOLOGY; Lugar: Berlin; Año: 2012 vol. 91 p. 633 - 636

BELLI C; BESTACH Y; FLORES G; SIEZA Y; GELEMUR M; VENTURINI C; NEGRI P; WATMAN N; BENGIÓ R; LARRIPA I

La Presencia del Alelo -308 A del TNFalfa se asocia con anemia y plaquetopenia en SMD

Hematologia; Lugar: Buenos Aires; Año: 2012 vol. 16 p. 1 - 7

BELLI C; BESTACH Y; SIEZA Y; GELEMUR M; GIUNTA M; FLORES MG; WATMAN N; BENGIO R; LARRIPA I

The presence of -308 TNFa is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes

BLOOD CELLS MOLECULES AND DISEASES; Lugar: La Jolla; Año: 2011 vol. 47 p. 255 - 258

BELLI C; PRATES V; ARBELBIDE J; NUCIFORA E; FLORES G; WATMAN N; NEGRI P; SAKAMOTO F; BENGIO R; LARRIPA I

Partial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patients

AMERICAN JOURNAL OF HEMATOLOGY; Año: 2011 vol. 86 p. 540 - 545

BENGIO R; RIVA M; MOIRAGHI B; LANARI E; MILONE J; BULLORSKY E; TEZANOS PINTO M; MURRO H; BIANCHINI M; LARRIPA I

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients. First multicenter argentinean study

LEUKEMIA AND LYMPHOMA; Año: 2011 vol. 52 p. 1720 - 1726

ROSSETTI L; RADIC P; ABELLEYRO M; LARRIPA I; DE BRASI C

Eighteen years of molecular genotyping the hemophilia inversion hotspot: from southern blot to inverse shifting-PCR

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; Lugar: Basel; Año: 2011 vol. 12 p. 7271 - 7285

BELLI C; ALU F; ALFONSO G; BIANCHINI M; LARRIPA I

Novel variant Ph translocation t(9;22;11)(q34;q11.2; p15) inv(9)(p13q34) in chronic myeloid leukemia involving a one step mechanism

CYTOGENETIC AND GENOME RESEARCH; Lugar: Basel; Año: 2011 vol. 132 p. 304 - 308

LARRIPA I

CITOGENETICA HUMANA: DEL MICROSCOPIO AL MICROARRAY

Hematologia; Lugar: Buenos Aires; Año: 2011 vol. 15 p. 27 - 34

GONZALEZ M; DE BRASI C; BIANCHINI M; GARGALLO P; MOIRAGHI B; BENGIÓ R; LARRIPA I

BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.

BLOOD CELLS MOLECULES AND DISEASES; Lugar: La Jolla; Año: 2010 vol. 45 p. 192 - 196

DE CAMPOS NEBEL M; LARRIPA I; GONZALEZ CID M

TopoisomeraseII-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombinations

PLOS ONE; Lugar: San Francisco; Año: 2010 vol. 5 p. 1 - 13

MAÑAS F.; PERALTA L; RAVIOLO J; GARCIA OVANDO; WEYERS A; UGNIA L; GONZALEZ CID M; LARRIPA I; GORLA N

Genotoxicity of glifosato assessed by the comet assay and cytogenetic test.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY; Lugar: Netherland; Año: 2009 vol. 28 p. 37 - 41

BIANCHINI M.; DE BRASI C; GARGALLO P.; GONZALEZ M; BENGIO R; LARRIPA I

Specific assesment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients.

EUROPEAN JOURNAL OF HAEMATOLOGY; Lugar: Copenhangen; Año: 2009 vol. 82 p. 292 - 300

MAÑAS F.; PERALTA L; RAVIOLO J; GARCIA OVANDO H; WEYERS A; UGNIA L; GONZALEZ CID M; LARRIPA I; GORLA N

Genotoxicity of AMPA environmental metabolite of glyphosate, assessed by the comet assay and cytogenetic test

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY; Lugar: New York; Año: 2009 vol. 72 p. 834 - 837

FUNDIA A; LARRIPA I; SLAVUTSKY I

Alteraciones genéticas, inestabilidad genomica y cancer en enfernedad celiaca

ACTA GASTROENTEROLOGICA LATINOAMERICANA.; Lugar: Buenos Aires; Año: 2009 vol. 39 p. 55 - 62

RADIC P; ROSSETTI L; ZUCCOLI J; ABELLEYRO M; LARRIPA I; DE BRASI C

Inverse shifting PCR based prenatal diagnosis of hemophilia-causative inversions involving int22h and int1h hotspots from chorionic villus samples.

PRENATAL DIAGNOSIS; Lugar: New York; Año: 2009 vol. 29 p. 1183 - 1185

CAVALIERE V; PAPADEMETRIO D; LORENZETTI M, M.; VALVA P; PRECIADO MV; GARGALLO P; LARRIPA I; MONREAL MB; PARDO M; HAJOS S; BLANCO G; ALVAREZ E

Caffeic Acid Phenylethyl Ester and MG-132 have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells.

TRANSLATIONAL ONCOLOGY; Año: 2009 vol. 2 p. 46 - 58

ROSSETTI L ; RADIC P; LARRIPA I; DE BRASI C

Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene

Journal of Thrombosis and Haemostasis; Lugar: England; Año: 2008 vol. 6 p. 830 - 836

FUNDIA A., COTTLIAR A,, LA MOTTA G, CRIVELLI A, GÓMEZ JC, SLAVUTSKY I, LARRIPA I

Analysis of genomic instability in adult-onset celiac patients by microsatellite instability

European Journal of Gastroenterogy and Hepatology; Lugar: England; Año: 2008

DE CAMPOS NEBEL M., LARRIPA I., GONZALEZ CID M.

Non-homologous end joing is the responsible pathway for the repair of fludarabine induced DNA double strand breaks in mammalian cells

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS; Lugar: Netherland; Año: 2008 vol. 646 p. 8 - 16

BIANCHINI M., MARTINELLI G., RENZULI M., GONZALEZ CID M., LARRIPA I.

cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostina and imatinib

CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Germany; Año: 2007 vol. 59 p. 349 - 369

ROSSETTI L., RADIC P., CANDELA M., PEREZ BIANCO R., DE TEZANOS PINTO M., GOODEVE A., LARRIPA I., DE BRASI C.

Sixteen novel haemophilia A causative mutations in the first argentinean series of severe molecular defects.

HAEMATOLOGICA; Lugar: Italy; Año: 2007 vol. 92 p. 842 - 845

BENGIO R., GARGALLO P., BARREYRO P., BITTON R., LARRIPA I

Leucemia Mieloide Crónica. Mecanismos genéticos de resistencia al imatinib

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2007 vol. 67 p. 71 - 74

JULIO A NAVONI1, MARCELA GONZÁLEZ CID2, MÓNICA OLIVERA1, JAVIER TSCHAMBLER3,GRACIELA BOVI MITRE3, IRENE LARRIPA2, EDDA VILLAAMIL LEPORI1

Daño al ADN asociado al contenido de arsénico urinario en una población de jóvenes expuesta al arsénico por el agua de bebida

ACTA TOXICOLóGICA ARGENTINA; Lugar: Buenos Aires; Año: 2006 vol. 14 p. 48 - 51

MAÑAS F., GONZALEZ CID M., GARCIA H., WEYERS I., UGNIA L, LARRIPA I., GORLA N.

La genotoxicidad del herbicida glifosato evaluada por el ensayo cometa y por la formacion de micronucleos en ratones tratados

Theoria; Lugar: Santiago de chile; Año: 2006 vol. 15 p. 53 - 60

ROSSETTI L., RADIC P., LARRIPA I., DEBRASI C

Genotyping the hemophilia inversion hotspot by use of inverse PCR

Clinical Chemestry; Lugar: Washington Dc ; Año: 2005 vol. 51 p. 1154 - 1158

GARGALLO P., CACHONE J., CHENA C., DUPONT J., RIVEROS D., LARRIPA I.,

Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events

CANCER GENETICS AND CYTOGENETICS; Lugar: USA; Año: 2005 vol. 161 p. 74 - 77

VELLON L., GONZALEZ CID M., DE CAMPOS NEBEL M.,LARRIPA I.

Additive apoptotic effect of STI571with the cytoprotective agent amifostine in K-562 cell line

CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Germany; Año: 2005 vol. 55 p. 602 - 608

BELLI C., LARRIPA I.

Clasificación y sistemas pronósticos en Sindromes mielodisplásicos

SIIC Salud; Año: 2005 vol. 13 p. 22 - 25

BELLI C, BOWEN D, DE BRASI C, LARRIPA I

A single multiplex analysis for all relevant activating N-Ras gene mutations using heteroduplex generators.

Br J Haematol; Lugar: England; Año: 2004 vol. 126 p. 602 - 605

FUNDIA A., DE BRASI C., LARRIPA I

Feasibility of cost effective approach to evaluate STR markers suitable for chimerism follow up

Molecular Diagnosis; Año: 2004 vol. 8 p. 87 - 91

ROSSETTI LC, CANDELA M, BIANCO RP, DE TEZANOS PINTO M, WESTERN A, GOODEVE A, LARRIPA IB, DE BRASI CD

Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature

Blood Coagulation and Fibrinolysis; Lugar: London; Año: 2004 vol. 15 p. 569 - 572

ROSSETTI LC, GOODEVE A, LARRIPA IB, DE BRASI CD.

Homeologous recombination between AluSx-sequences as a cause of hemophilia.

HUMAN MUTATION; Lugar: New York; Año: 2004 vol. 24 p. 440 - 450

GARGALLO P, HAGEMEIJER A, VASSALLU P, KORNBLIHTT L, HELLER P, MOLINAS F, LARRIPA I.

Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis.

Cancer Genet Cytogenet.; Lugar: New York; Año: 2004 vol. 154 p. 72 - 76